Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Investigation of how sex steroids and nicotinic acetylcholine receptors promote cocaine self-administration

Award Number: K00DA057923
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 12/01/2020
PERIOD OF PERFORMANCE END DATE: 01/31/2027

Group Awards By:

View Award Description

Investigation of how sex steroids and nicotinic acetylcholine receptors promote cocaine self-administration - PROJECT SUMMARY/ABSTRACT About 12 million individuals over the age of 12 have a substance use disorder (SUD). Cocaine is involved in about 1 in 5 overdoses in the United States and is abused by both men and women. Women are more vulnerable to the rewarding effects of cocaine and more rapidly progress from initial use to dependence than men but the neurobiological mechanisms that contribute to these differences are yet to be determined. A limitation of the current work investigating sex differences in preclinical research is that the research is primarily focused on hormonal contributions that may be driving sex differences. There is little understanding of how sex steroids and other neurobiological mechanisms contribute to cocaine dependence. The overall goal of this project is to identify the effects of a history of cocaine self-administration on sex steroids and nicotinic acetylcholine receptor (nAChRs) subunit expression and to test the hypothesis that decreased nAChRs alpha 5 (ɑ5) in the dorsal hippocampus (dHIPP) produced by decreased progesterone levels promote cocaine self-administration behavior. Aim 1 will use single-cell transcriptomics to identify sex differences in the dysregulated transcriptional networks in rats with a history of compulsive-like cocaine self-administration using brain (dHIPP), adrenal, pituitary, reproductive organ samples. Aim 2 will causally investigate the role of the nAChR ɑ5 in the dHIPP and progesterone on cocaine self-administration behavior using an AAV-ShRNA to knock down nAChRs ɑ5 in the dHIPP and pharmacology to block the progesterone receptor. These projects will be the first to look at associations between sex steroids and nAChR ɑ5 in the dHIPP on cocaine selfadministration in both sexes. My Sponsor, Dr. Olivier George (UCSD) is an expert on the neurobiology of drugs of abuse and addiction and is recognized as an innovative leader in the field of drug abuse and, therefore, the perfect fit to mentor me for the proposed research. The proposed Research and Training Plans will deepen my knowledge of transcriptomics, the cholinergic system, the hippocampus, and neuroendocrinology in addictionlike phenotypes and will expand my expertise in cocaine dependency. The training I will receive in single-cell transcriptomics, ELISAs, bioinformatics, intrajugular catheter surgeries, and advanced operant paradigms will give me the skills necessary to answer questions focused on cell-specific differences in males and females that may be driving dysregulation of reward circuitry pre- and post-drug exposure. The training I have received in the F99 phase and the training I will receive in the K00 phase will allow me to establish a lab where I can research my long-term research goal of investigating the mechanisms underlying maladaptive addiction behaviors and how these behaviors differentiate by sex.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $92,029 )
2026	2026	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	000	6	1/14/2026	NON-COMPETING CONTINUATION	$92,029
														Subtotal = $92,029

Issue Date FY: 2025 ( Subtotal = $87,759 )
2025	2025	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	003	5	7/18/2025	NON-COMPETING CONTINUATION	$87,759
2025	2024	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	001	4	5/27/2025	TERMINATION	$0
2025	2024	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	000	4	5/12/2025	TERMINATION	$0
2025	2024	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	002	4	7/7/2025	OTHER REVISION	$0
														Subtotal = $87,759

Issue Date FY: 2024 ( Subtotal = $83,486 )
2024	2024	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	000	4	1/24/2024	NON-COMPETING CONTINUATION	$83,486
														Subtotal = $83,486

Issue Date FY: 2023 ( Subtotal = $80,913 )
2023	2023	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	001	3	2/7/2023	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$0
2023	2023	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR	LA JOLLA	CA	92093	SAN DIEGO	USA	Drug Use and Addiction Research Programs	000	3	1/25/2023	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$80,913
														Subtotal = $80,913

Grand Total All Awards = $344,187

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Investigation of how sex steroids and nicotinic acetylcholine receptors promote cocaine self-administration

Award Number: K00DA057923

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 12/01/2020

PERIOD OF PERFORMANCE END DATE: 01/31/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer